Novartis Stops Drug Marketing Amid Safety Concerns

By Marius Meland · March 30, 2007, 12:00 AM EDT

Nudged by the U.S. Food and Drug Administration, Switzerland's Novartis on Friday agreed to stop marketing the drug Zelnorm amid concerns the drug could trigger serious heart problems....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Marius

April 16, 2011
Welcome To The New Law360
March 24, 2009
CVT Shareholders Sue To Stop $1.4B Biotech Merger
November 09, 2007
Stunning Lawyers, Merck Plans To Settle Vioxx Cases
April 02, 2007
Pfizer Pays $34.7M To Settle Genotropin Charges
April 02, 2007
Tenet To Pay $10M To Settle With SEC
April 02, 2007
High Court Refuses Ranbaxy's Lipitor Appeal
March 30, 2007
Federal Circuit Backs Teva In Patent Challenge
March 22, 2007
Appeals Court Deals Blow To Pfizer
March 20, 2007
Pfizer Wins Celebrex Challenge
March 20, 2007
Medtronic Wins Appeal Over Spinal Technology